Patent Board Grants Review Of Oral Pulsed Dosed Drug Delivery System Patent

(November 22, 2016, 12:18 PM EST) -- ALEXANDRIA, Va. — Arguments by Mylan Pharmaceuticals Inc. that a patented drug delivery system associated with the attention deficit hyperactivity disorder (ADHD) drug Adderall XR is invalid were well received Nov....

To view the full article, register now.